医薬品用ゼラチンの世界市場：市場規模・予測 - タイプ別、用途別、供給源別、地域別分析、2023～2030年

世界の医薬品用ゼラチンの市場規模は、2022年に約12億1,000万米ドルに達し、2023～2030年の予測期間中に5.5％以上の健全な成長率で推移すると予測されています。

医薬品用ゼラチンはコラーゲン由来のタンパク質で、通常、骨、皮膚、結合組織などの動物性原料から得られます。一般的に、カプセル、ソフトジェル、錠剤、その他の剤形など、様々な医薬品の製造における主要成分として使用されます。医薬品用ゼラチン市場は、慢性疾患の流行や製薬産業の拡大などの要因により拡大しています。医薬品用ゼラチンは安定したゲルマトリックスを形成する能力があるため、薬剤のカプセル化や経口投与に適しています。その結果、医薬品用ゼラチンの需要は、予測期間中の2023～2030年の間に国際市場で徐々に増加しています。

慢性疾患の患者は、しばしば長期の投薬レジメンを必要とします。ゼラチンをベースとするカプセルやソフトジェルは、飲み込みやすさ、滑らかなテクスチャー、味覚マスキング機能により、多くの患者に好まれています。患者のコンプライアンスと処方された薬物療法へのアドヒアランスの向上は、慢性疾患のより良い管理に貢献し、ゼラチンベースの医薬品需要をさらに促進します。国連の報告書によると、慢性疾患は世界全体の死亡者数の70%を占めると予想されており、2030年には世界全体の疾病負担は56%になると予測されています。最も大きな成長が見込まれるのはアフリカと東地中海地域です。さらに、ゼラチンは、ゲル化、増粘、安定化などのユニークな特性により、さまざまな医薬製剤に使用できる汎用性の高い賦形剤です。特に、固形と液体の両方の薬剤のカプセル化に適しており、慢性疾患の治療法を開発する製薬会社にとって好ましい選択肢となっています。医薬品用ゼラチン市場を牽引するもう一つの重要な要因は、製薬産業の拡大です。製薬産業は、ゼラチンをベースとした医薬品剤形の需要を促進し、ドラッグデリバリー技術の革新を奨励し、製造能力を世界中に拡大することによって、医薬品用ゼラチンの成長に資する環境を醸成しています。また、欧州製薬団体連合会（European Federation of Pharmaceutical Industries and Associations）によると、2021年の世界の医薬品売上高に占める北米の割合は49.1%であるのに対し、欧州は23.4%です。ソフトジェルカプセル、マイクロスフェア、ナノ粒子などのゼラチンベースのドラッグデリバリーシステムは、薬物の溶解度、バイオアベイラビリティ、放出プロファイルの制御を強化する能力により人気を集めています。さらに、ゼラチンをベースとする医薬品の技術的進歩と政府の医療支出の増加は、予測期間中、市場に有利な成長機会をもたらすと予想されます。しかし、代替製剤原料の入手可能性や原料価格の変動は、2023～2030年の予測期間を通じて市場全体の成長を阻害することになると思われます。

医薬品用ゼラチンの世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカなどです。北米は2022年に市場を独占したが、これは同地域で処方薬の承認が増加しているためです。医療用医薬品の承認が増加していることは、製薬部門が研究開発を継続していることを示しています。この研究開発では、製剤、配合剤、ドラッグデリバリー技術の研究が頻繁に行われています。生体適合性、生分解性、加工の容易さといったゼラチンの特徴は、医薬品開発の革新を目指す製剤メーカーにとって魅力的な選択肢となっています。米国食品医薬品局によると、市販が承認されている医療用医薬品は2万種類を超えます。また、Health Policy Instituteによれば、米国では成人の66％以上が処方薬を使用しています。この地域の圧倒的な実績は、医薬品用ゼラチンの需要全体を促進すると予想されます。さらに、アジア太平洋地域は、同地域におけるヘルスケア支出の増加などの要因により、予測期間中に最も急成長すると予想されています。ヘルスケア支出の増加は、病院、診療所、薬局などのヘルスケアインフラの拡大をもたらす可能性があります。このような拡大は、医薬品の生産量と消費量の増加につながり、結果として医薬品用ゼラチンの需要を増加させます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も掲載しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界の医薬品用ゼラチン市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 産業の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 世界の医薬品用ゼラチンの市場力学

• 医薬品用ゼラチン市場の影響分析（2020～2030年）
  • 市場促進要因
    • 慢性疾患の有病率の増加
    • 製薬産業の拡大
  • 市場の課題
    • 代替製剤原料の入手可能性
    • 原材料価格の変動
  • 市場機会
    • ゼラチンベースの医薬品における技術の進歩
    • 政府のヘルスケア支出の増加

第4章 世界の医薬品用ゼラチン市場の産業分析

• ポーターのファイブフォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターのファイブフォース影響分析
• PEST分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主な成功戦略
• COVID-19影響分析
• 破壊的動向
• 産業専門家の視点
• アナリストの結論・提言

第5章 医薬品用ゼラチンの世界市場：タイプ別

• 市場スナップショット
• 医薬品用ゼラチンの世界市場：タイプ別、実績 - ポテンシャル分析
• 医薬品用ゼラチンの世界市場：タイプ別、推定・予測、 2020～2030年
• 医薬品用ゼラチン市場、サブセグメント分析
  • タイプAゼラチン
  • タイプBゼラチン

第6章 医薬品用ゼラチンの世界市場：用途別

• 市場スナップショット
• 医薬品用ゼラチンの世界市場：用途別、実績 - ポテンシャル分析
• 医薬品用ゼラチンの世界市場：用途別、推定・予測、 2020～2030年
• 医薬品用ゼラチン市場、サブセグメント分析
  • カプセル・ソフトジェルカプセル
  • コーティング剤
  • 非経口製剤
  • その他の用途

第7章 医薬品用ゼラチンの世界市場：供給源別

• 市場スナップショット
• 医薬品用ゼラチンの世界市場：供給源別、実績 - ポテンシャル分析
• 医薬品用ゼラチンの世界市場：供給源別、推定・予測、 2020～2030年
• 医薬品用ゼラチン市場、サブセグメント分析
  • 牛ゼラチン
  • 豚ゼラチン
  • その他の供給源

第8章 医薬品用ゼラチンの世界市場：地域別分析

• 主な主要国
• 主な新興国
• 医薬品用ゼラチン市場の地域別市場スナップショット
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他の中東・アフリカ

第9章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • PB Leiner GmbH
  • Tessenderlo Group
  • Weishardt Holding GmbH & Co. KG
  • Gelita AG
  • LAPI Gelatine S.p.A.
  • Croda International Plc
  • Eastman Chemical Company
  • Rousselot Inc
  • Gelnex Pharmaceuticals
  • Norland Products Inc

第10章 調査プロセス

LIST OF TABLES

• TABLE 1.Global Pharmaceutical Gelatin Market, report scope
• TABLE 2.Global Pharmaceutical Gelatin Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3.Global Pharmaceutical Gelatin Market estimates & forecasts by Type 2020-2030 (USD Billion)
• TABLE 4.Global Pharmaceutical Gelatin Market estimates & forecasts by Application 2020-2030 (USD Billion)
• TABLE 5.Global Pharmaceutical Gelatin Market estimates & forecasts by Source 2020-2030 (USD Billion)
• TABLE 6.Global Pharmaceutical Gelatin Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 7.Global Pharmaceutical Gelatin Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8.Global Pharmaceutical Gelatin Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9.Global Pharmaceutical Gelatin Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10.Global Pharmaceutical Gelatin Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11.Global Pharmaceutical Gelatin Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12.Global Pharmaceutical Gelatin Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13.Global Pharmaceutical Gelatin Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14.Global Pharmaceutical Gelatin Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15.Global Pharmaceutical Gelatin Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16.U.S. Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 17.U.S. Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 18.U.S. Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 19.Canada Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 20.Canada Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 21.Canada Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 22.UK Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 23.UK Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 24.UK Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 25.Germany Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 26.Germany Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 27.Germany Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 28.France Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 29.France Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 30.France Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 31.Italy Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 32.Italy Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 33.Italy Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 34.Spain Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 35.Spain Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 36.Spain Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 37.RoE Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 38.RoE Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 39.RoE Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 40.China Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 41.China Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 42.China Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 43.India Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 44.India Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 45.India Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 46.Japan Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 47.Japan Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 48.Japan Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 49.South Korea Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 50.South Korea Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 51.South Korea Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 52.Australia Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 53.Australia Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 54.Australia Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 55.RoAPAC Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 56.RoAPAC Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 57.RoAPAC Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 58.Brazil Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 59.Brazil Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 60.Brazil Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 61.Mexico Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 62.Mexico Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 63.Mexico Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 64.RoLA Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 65.RoLA Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 66.RoLA Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 67.Saudi Arabia Pharmaceutical Gelatin Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 68.South Africa Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 69.RoMEA Pharmaceutical Gelatin Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 70.List of secondary sources, used in the study of global Pharmaceutical Gelatin Market
• TABLE 71.List of primary sources, used in the study of global Pharmaceutical Gelatin Market
• TABLE 72.Years considered for the study
• TABLE 73.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1.Global Pharmaceutical Gelatin Market, research methodology
• FIG 2.Global Pharmaceutical Gelatin Market, Market estimation techniques
• FIG 3.Global Market size estimates & forecast methods
• FIG 4.Global Pharmaceutical Gelatin Market, key trends 2022
• FIG 5.Global Pharmaceutical Gelatin Market, growth prospects 2023-2030
• FIG 6.Global Pharmaceutical Gelatin Market, porters 5 force model
• FIG 7.Global Pharmaceutical Gelatin Market, pest analysis
• FIG 8.Global Pharmaceutical Gelatin Market, value chain analysis
• FIG 9.Global Pharmaceutical Gelatin Market by segment, 2020 & 2030 (USD Billion)
• FIG 10.Global Pharmaceutical Gelatin Market by segment, 2020 & 2030 (USD Billion)
• FIG 11.Global Pharmaceutical Gelatin Market by segment, 2020 & 2030 (USD Billion)
• FIG 12.Global Pharmaceutical Gelatin Market by segment, 2020 & 2030 (USD Billion)
• FIG 13.Global Pharmaceutical Gelatin Market by segment, 2020 & 2030 (USD Billion)
• FIG 14.Global Pharmaceutical Gelatin Market, regional snapshot 2020 & 2030
• FIG 15.North America Pharmaceutical Gelatin Market 2020 & 2030 (USD Billion)
• FIG 16.Europe Pharmaceutical Gelatin Market 2020 & 2030 (USD Billion)
• FIG 17.Asia Pacific Pharmaceutical Gelatin Market 2020 & 2030 (USD Billion)
• FIG 18.Latin America Pharmaceutical Gelatin Market 2020 & 2030 (USD Billion)
• FIG 19.Middle East & Africa Pharmaceutical Gelatin Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Pharmaceutical Gelatin Market is valued at approximately USD 1.21 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 5.5% over the forecast period 2023-2030. Pharmaceutical Gelatin is a protein derived from collagen, typically obtained from animal sources such as bones, skin, and connective tissues. It is commonly used as a key ingredient in the production of various pharmaceutical products, including capsules, soft gels, tablets, and other dosage forms. The Pharmaceutical Gelatin market is expanding because of factors such as the growing prevalence of chronic illnesses and the expansion of the pharmaceutical industry. Pharmaceutical Gelatin's ability to form a stable gel matrix makes it suitable for encapsulating and delivering medications orally. As a result, the demand for Pharmaceutical Gelatin has progressively increased in the international market during the forecast period 2023-2030.

Patients with chronic illnesses often require long-term medication regimens. Gelatin-based capsules and soft gels are preferred by many patients due to their ease of swallowing, smooth texture, and taste-masking capabilities. Improved patient compliance and adherence to prescribed medication regimens can contribute to better management of chronic conditions, further driving the demand for gelatin-based pharmaceutical products. According to the United Nations report, chronic diseases are anticipated to account for 70% of all global fatalities, while the global disease burden will be 56% by the year 2030. The most significant growth is expected in the African and Eastern Mediterranean regions. Furthermore, gelatin is a versatile excipient that can be used in various pharmaceutical formulations due to its unique properties such as gelling, thickening, and stabilizing abilities. It is particularly well-suited for the encapsulation of both solid and liquid drugs, making it a preferred choice for pharmaceutical companies developing treatments for chronic illnesses. Another important factor that drives the Pharmaceutical Gelatin market is an expansion of the pharmaceutical industry. The pharmaceutical industry fosters a conducive environment for the growth of pharmaceutical gelatin by driving demand for gelatin-based pharmaceutical dosage forms, encouraging innovation in drug delivery technologies, and expanding manufacturing capabilities across the world. In addition, as per the European Federation of Pharmaceutical Industries and Associations, in 2021 North America accounted for 49.1% of world pharmaceutical sales compared with 23.4% for Europe. Gelatin-based drug delivery systems, such as softgel capsules, microspheres, and nanoparticles, are gaining popularity due to their ability to enhance drug solubility, bioavailability, and controlled release profiles. Moreover, technological advancements in gelatin-based pharmaceuticals and increasing government healthcare expenditure are anticipated to create a lucrative growth opportunity for the market over the forecast period. However, the availability of alternative formulation ingredients and fluctuations in the prices of raw materials are going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Pharmaceutical Gelatin Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing approvals of prescription drug products in the region. Increased prescription medicine approvals indicate that the pharmaceutical sector is continuing to conduct research and development operations. This R&D frequently entails investigating drug formulations, combination medicines, and delivery technologies. Gelatin's features, such as biocompatibility, biodegradability, and ease of processing, make it an appealing choice for formulators seeking to innovate in drug development. According to the U.S. Food and Drug Administration, there are over 20,000 prescription drug products approved for marketing. In addition, as per the Health Policy Institute, more than 66% of all adults in the United States use prescription drugs. The region's dominant performance is anticipated to propel the overall demand for Pharmaceutical Gelatin. Furthermore, Asia Pacific is expected to grow fastest during the forecast period, owing to factors such as increasing healthcare expenditure in the region. Increased healthcare spending may result in the expansion of healthcare infrastructure, including hospitals, clinics, and pharmacies. This expansion can lead to a higher volume of drug production and consumption, consequently increasing the demand for pharmaceutical gelatin.

Major market players included in this report are:

• PB Leiner GmbH
• Tessenderlo Group
• Weishardt Holding GmbH & Co. KG
• Gelita AG
• LAPI Gelatine S.p.A.
• Croda International Plc
• Eastman Chemical Company
• Rousselot Inc.
• Gelnex Pharmaceuticals
• Norland Products Inc.

Recent Developments in the Market:

• In December 2023, Amneal Pharmaceuticals, Inc. and Strides Pharma Science Limited announced the addition of Icosapent ethyl acid soft gel capsules, a product based on VASCEPA. Icosapent ethyl acid soft gel capsules 0.5g and 1g are an ethyl ester of eicosapentaenoic acid (EPA) advised as an addition to diet to lower triglyceride levels in adult patients with severe hypertriglyceridemia. Thus, Soft gel capsules typically require pharmaceutical-grade gelatin for their casing which are anticipated to create lucrative opportunities for the manufacturers and suppliers

Global Pharmaceutical Gelatin Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Type, Application, Source, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type

• Type A Gelatin
• Type B Gelatin

By Application

• Capsules and Softgel Capsules
• Coatings
• Parenteral Formulations
• Other Applications

By Source

• Bovine Gelatin
• Porcine Gelatin
• Other Sources

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1.Pharmaceutical Gelatin Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2.Pharmaceutical Gelatin Market, by Type, 2020-2030 (USD Billion)
  • 1.2.3.Pharmaceutical Gelatin Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4.Pharmaceutical Gelatin Market, by Source, 2020-2030 (USD Billion)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Pharmaceutical Gelatin Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Pharmaceutical Gelatin Market Dynamics

• 3.1.Pharmaceutical Gelatin Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Growing Prevalence of Chronic Illnesses
    • 3.1.1.2.Expansion of Pharmaceutical Industry
  • 3.1.2.Market Challenges
    • 3.1.2.1.Availability of Alternative Formulation Ingredients
    • 3.1.2.2.Fluctuations in Prices of Raw Materials
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Technological Advancements in Gelatin-Based Pharmaceuticals
    • 3.1.3.2.Increasing Government Healthcare Expenditure

Chapter 4.Global Pharmaceutical Gelatin Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Pharmaceutical Gelatin Market, by Type

• 5.1.Market Snapshot
• 5.2.Global Pharmaceutical Gelatin Market by Type, Performance - Potential Analysis
• 5.3.Global Pharmaceutical Gelatin Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
• 5.4.Pharmaceutical Gelatin Market, Sub Segment Analysis
  • 5.4.1.Type A Gelatin
  • 5.4.2.Type B Gelatin

Chapter 6.Global Pharmaceutical Gelatin Market, by Application

• 6.1.Market Snapshot
• 6.2.Global Pharmaceutical Gelatin Market by Application, Performance - Potential Analysis
• 6.3.Global Pharmaceutical Gelatin Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4.Pharmaceutical Gelatin Market, Sub Segment Analysis
  • 6.4.1.Capsules and Softgel Capsules
  • 6.4.2.Coatings
  • 6.4.3.Parenteral Formulations
  • 6.4.4.Other Applications

Chapter 7.Global Pharmaceutical Gelatin Market, by Source

• 7.1.Market Snapshot
• 7.2.Global Pharmaceutical Gelatin Market by Source, Performance - Potential Analysis
• 7.3.Global Pharmaceutical Gelatin Market Estimates & Forecasts by Source 2020-2030 (USD Billion)
• 7.4.Pharmaceutical Gelatin Market, Sub Segment Analysis
  • 7.4.1.Bovine Gelatin
  • 7.4.2.Porcine Gelatin
  • 7.4.3.Other Sources

Chapter 8.Global Pharmaceutical Gelatin Market, Regional Analysis

• 8.1.Top Leading Countries
• 8.2.Top Emerging Countries
• 8.3.Pharmaceutical Gelatin Market, Regional Market Snapshot
• 8.4.North America Pharmaceutical Gelatin Market
  • 8.4.1.U.S. Pharmaceutical Gelatin Market
    • 8.4.1.1.Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2.Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3.Source breakdown estimates & forecasts, 2020-2030
  • 8.4.2.Canada Pharmaceutical Gelatin Market
• 8.5.Europe Pharmaceutical Gelatin Market Snapshot
  • 8.5.1.U.K. Pharmaceutical Gelatin Market
  • 8.5.2.Germany Pharmaceutical Gelatin Market
  • 8.5.3.France Pharmaceutical Gelatin Market
  • 8.5.4.Spain Pharmaceutical Gelatin Market
  • 8.5.5.Italy Pharmaceutical Gelatin Market
  • 8.5.6.Rest of Europe Pharmaceutical Gelatin Market
• 8.6.Asia-Pacific Pharmaceutical Gelatin Market Snapshot
  • 8.6.1.China Pharmaceutical Gelatin Market
  • 8.6.2.India Pharmaceutical Gelatin Market
  • 8.6.3.Japan Pharmaceutical Gelatin Market
  • 8.6.4.Australia Pharmaceutical Gelatin Market
  • 8.6.5.South Korea Pharmaceutical Gelatin Market
  • 8.6.6.Rest of Asia Pacific Pharmaceutical Gelatin Market
• 8.7.Latin America Pharmaceutical Gelatin Market Snapshot
  • 8.7.1.Brazil Pharmaceutical Gelatin Market
  • 8.7.2.Mexico Pharmaceutical Gelatin Market
• 8.8.Middle East & Africa Pharmaceutical Gelatin Market
  • 8.8.1.Saudi Arabia Pharmaceutical Gelatin Market
  • 8.8.2.South Africa Pharmaceutical Gelatin Market
  • 8.8.3.Rest of Middle East & Africa Pharmaceutical Gelatin Market

Chapter 9.Competitive Intelligence

• 9.1.Key Company SWOT Analysis
• 9.2.Top Market Strategies
• 9.3.Company Profiles
  • 9.3.1.PB Leiner GmbH
    • 9.3.1.1.Key Information
    • 9.3.1.2.Overview
    • 9.3.1.3.Financial (Subject to Data Availability)
    • 9.3.1.4.Product Summary
    • 9.3.1.5.Recent Developments
  • 9.3.2.Tessenderlo Group
  • 9.3.3.Weishardt Holding GmbH & Co. KG
  • 9.3.4.Gelita AG
  • 9.3.5.LAPI Gelatine S.p.A.
  • 9.3.6.Croda International Plc
  • 9.3.7.Eastman Chemical Company
  • 9.3.8.Rousselot Inc
  • 9.3.9.Gelnex Pharmaceuticals
  • 9.3.10.Norland Products Inc

Chapter 10.Research Process

• 10.1.Research Process
  • 10.1.1.Data Mining
  • 10.1.2.Analysis
  • 10.1.3.Market Estimation
  • 10.1.4.Validation
  • 10.1.5.Publishing
• 10.2.Research Attributes
• 10.3.Research Assumption